PHARMACEUTICALS ULTRASECTOR PROFUND is a registered fund series of ProFunds (series S000003093). Net assets $3.4M as of 2026-04-30. Index fund.
Showing 15 of 70 holdings by value.
| Holding | Ticker | Value | % of fund |
|---|---|---|---|
| HSBC SECURITIES (USA), INC. B 3.5 , 5/01/2026 | — | $246K | 730.02% |
| SOCIETE' GENERALE 3.52 , 5/01/2026 | — | $210K | 623.19% |
| CF Secured 3.52 , 5/01/2026 | — | $185K | 549.00% |
| NATWEST MARKETS PLC 3.51 , 5/01/2026 | — | $122K | 362.04% |
| ORGANON & COMPANY | — | $92K | 272.76% |
| UMB FINANCIAL CORP. 3.37 , 5/01/2026 | — | $71K | 210.70% |
| CORCEPT THERAPEUTICS INC | — | $61K | 181.67% |
| ENLIVEN THERAPEUTICS INC | — | $60K | 176.92% |
| AXSOME THERAPEUTICS INC | — | $58K | 171.39% |
| OMEROS CORP | — | $54K | 161.26% |
| PERRIGO COMPANY PLC | — | $54K | 159.02% |
| DEFINIUM THERAPEUTICS INC | — | $52K | 154.73% |
| NEKTAR THERAPEUTICS | — | $51K | 152.68% |
| TREVI THERAPEUTICS INC | — | $51K | 151.82% |
| TERNS PHARMACEUTICALS INC | — | $50K | 149.06% |
| Report date | Net assets |
|---|---|
| 2026-04-30 | $3.4M |
| 2026-01-31 | $3.8M |
| 2025-10-31 | $3.0M |
| 2025-07-31 | $2.5M |
| 2025-04-30 | $3.0M |
| 2025-01-31 | $2.8M |
| 2024-10-31 | $2.9M |
| 2024-07-31 | $3.1M |